Affordable Access

deepdyve-link
Publisher Website

Molecular profiles in foregut oncology.

Authors
  • Sukharamwala, Prashant1
  • Hennessey, Daniel1
  • Wood, Thomas1
  • Singh, Shelly1
  • Ryan, Carrie1
  • Rosemurgy, Alexander2
  • 1 Florida Hospital Tampa, 3000 Medical Park Drive Suite 310, Tampa, FL 33613, USA.
  • 2 Florida Hospital Tampa, 3000 Medical Park Drive Suite 310, Tampa, FL 33613, USA. Electronic address: [email protected]
Type
Published Article
Journal
Cancer Genetics
Publisher
Elsevier
Publication Date
Dec 01, 2016
Volume
209
Issue
12
Pages
537–553
Identifiers
DOI: 10.1016/j.cancergen.2016.09.008
PMID: 27887938
Source
Medline
Keywords
License
Unknown

Abstract

Oncology is and will continue to evolve resulting from a better understanding of the biology and intrinsic genetic profile of each cancer. Tumor biomarkers and targeted therapies are the new face of precision medicine, so it is essential for all physicians caring for cancer patients to understand and assist patients in understanding the role and importance of such markers and strategies to target them. This review was initiated in an attempt to identify, characterize, and discuss literature supporting clinically relevant molecular markers and interventions. The efficacy of targeting specific markers will be examined with data from clinical trials focusing on treatments for esophageal, gastric, liver, gallbladder, biliary tract, and pancreatic cancers.

Report this publication

Statistics

Seen <100 times